Robust Q3 for Bard

Interventional firm C.R. Bard reported 2004 fiscal third-quarter net sales of $421.9 million, up 17% compared with $361.8 million posted in the same quarter last year.

For the period (end-September 30), the Murray Hill, NJ-based vendor had net income of $102.4 million, a 99% increase compared with net income of $51.5 million a year ago.

Included in the firm's third-quarter 2004 results were certain items that increased net income by $33.8 million. This includes a gain of $30.8 million (after tax) related to the previously announced sale of Bard's endoscopic technologies division.

Excluding the items comprising the $33.8 million one-time gain, the company's net income increased 33% compared with the third quarter of 2003, the company said.

By staff writers
October 20, 2004

Related Reading

Reinsdorf joins Bard, October 15, 2004

ConMed completes Bard endoscopic acquisition, October 1, 2004

Settlement in Immunomedics patent case, September 30, 2004

Bard to unload endoscopic assets, August 18, 2004

Bard ups Q1 forecast, March 10, 2004

Copyright © 2004

Page 1 of 180
Next Page